Antisense Therapeutics - a purpose driven biotech with global potential
It is estimated that over 300 million people in the world are impacted by rare diseases. In a recent study it was estimated that rare...
Antisense Therapeutics - a purpose driven biotech with global potential
Recce Pharmaceuticals Limited – A revolution in development of treating superbugs
Antisense shares have increased by 60% after Sarepta results
mRNA and Antisense biotech - attracting the large fund managers and defining 2020
Ionis Pharmaceuticals - A force for life
Antisense Therapeutics Limited dual-lists in Europe